Huawei Health Vaccine (301207.SZ) released its semi-annual performance, with a net income of 25.2744 million yuan, a year-on-year decrease of 76.65%.

Hualan Vaccine (301207.SZ) released the semi-annual report for 2024, and the company achieved revenue of 3...

Zhixin Finance APP news, Hualan Vaccine (301207.SZ) released the semi-annual report for 2024, with a revenue of 35.529 million yuan during the reporting period, a decrease of 76.25% year-on-year; net income attributable to shareholders of the listed company decreased by 76.65% to 25.2744 million yuan; net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 21.3215 million yuan; and the basic earnings per share was 0.0421 yuan/share.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

华兰疫苗(301207.SZ)发上半年业绩，净利润2527.44万元，同比减少76.65%

Huawei Health Vaccine (301207.SZ) released its semi-annual performance, with a net income of 25.2744 million yuan, a year-on-year decrease of 76.65%.

Risk Disclaimer

Statement